News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Nash Huw M.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/17/2023 |
4
| Nash Huw M. (COO & CBO) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Granted 78,600 options to buy
@ $9.15, valued at
$719.2k
Granted 52,400 restricted stock units
@ $0 |
|
| 12/09/2022 |
4
| Nash Huw M. (COO & CBO) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Granted 62,000 options to buy
@ $7.07, valued at
$438.3k
|
|
| 03/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2022 |
4
| Nash Huw M. (COO & CBO) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Sold 1,497 shares
@ $22.467, valued at
$33.6k
Sold 2,103 shares
@ $23.4042, valued at
$49.2k
Sold 200 shares
@ $24.07, valued at
$4.8k
Exercised 3,800 options to buy
@ $2.19, valued at
$8.3k
|
|
| 12/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/03/2021 |
4
| Nash Huw M. (COO & CBO) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Sold 2,190 shares
@ $23.407, valued at
$51.3k
Sold 1,610 shares
@ $23.7237, valued at
$38.2k
Sold 1,900 shares
@ $25, valued at
$47.5k
Exercised 3,800 options to buy
@ $2.19, valued at
$8.3k
Exercised 1,900 options to buy
@ $2.19, valued at
$4.2k
|
|
| 10/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/18/2020 |
4
| Nash Huw M. (COO & CBO) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Sold 41,985 shares
@ $60, valued at
$2.5M
Sold 8,015 shares
@ $60, valued at
$480.9k
Exercised 41,985 options to buy
@ $0.6, valued at
$25.2k
Exercised 8,015 options to buy
@ $0.6, valued at
$4.8k
|
|
| 12/03/2020 |
4
| Nash Huw M. (COO & CBO) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Sold 2,719 shares
@ $49.1885, valued at
$133.7k
Sold 2,481 shares
@ $50.0214, valued at
$124.1k
Sold 100 shares
@ $51.45, valued at
$5.1k
Sold 400 shares
@ $52.72, valued at
$21.1k
Exercised 5,700 options to buy
@ $2.19, valued at
$12.5k
|
|
| 11/10/2020 |
4
| Nash Huw M. (COO & CBO) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Sold 50,000 shares
@ $45, valued at
$2.3M
Exercised 36,586 options to buy
@ $0.6, valued at
$22k
Exercised 13,414 options to buy
@ $2.19, valued at
$29.4k
|
|
| 11/04/2020 |
4
| Nash Huw M. (COO & CBO) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Sold 3,164 shares
@ $36.5945, valued at
$115.8k
Sold 2,536 shares
@ $37.983, valued at
$96.3k
Exercised 5,700 options to buy
@ $2.19, valued at
$12.5k
|
|
| 10/05/2020 |
4
| Nash Huw M. (COO & CBO) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Sold 3,400 shares
@ $34.3288, valued at
$116.7k
Sold 2,300 shares
@ $34.862, valued at
$80.2k
Exercised 5,700 options to buy
@ $2.19, valued at
$12.5k
|
|
| 09/10/2020 |
4
| Nash Huw M. (COO & CBO) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Sold 30,718 shares
@ $30, valued at
$921.5k
Sold 17,201 shares
@ $30, valued at
$516k
Exercised 30,718 options to buy
@ $2.19, valued at
$67.3k
Exercised 17,201 options to buy
@ $2.19, valued at
$37.7k
|
|
| 09/03/2020 |
4
| Nash Huw M. (COO & CBO) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Sold 5,000 shares
@ $27.603, valued at
$138k
Sold 700 shares
@ $28.7109, valued at
$20.1k
Exercised 5,700 options to buy
@ $2.19, valued at
$12.5k
|
|
| 08/31/2020 |
4
| Nash Huw M. (COO & CBO) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Sold 2,081 shares
@ $30, valued at
$62.4k
Exercised 2,081 options to buy
@ $2.19, valued at
$4.6k
|
|
| 08/04/2020 |
4
| Nash Huw M. (COO & CBO) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Sold 5,700 shares
@ $24.7269, valued at
$140.9k
Exercised 5,700 options to buy
@ $2.19, valued at
$12.5k
|
|
| 07/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/09/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2020 |
4
| Nash Huw M. (COO & CBO) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Sold 1,607 shares
@ $27.0823, valued at
$43.5k
Sold 500 shares
@ $27.484, valued at
$13.7k
Exercised 2,107 options to buy
@ $2.19, valued at
$4.6k
|
|
| 03/26/2020 |
4
| Nash Huw M. (COO & CBO) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Granted 60,000 options to buy
@ $20.25, valued at
$1.2M
|
|
| 03/04/2020 |
4
| Nash Huw M. (COO & CBO) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Sold 33,148 shares
@ $25.6636, valued at
$850.7k
Sold 15,995 shares
@ $26.374, valued at
$421.9k
Exercised 6,324 options to buy
@ $0.4, valued at
$2.5k
Exercised 42,779 options to buy
@ $2.19, valued at
$93.7k
|
|
| 06/18/2019 |
3
| Nash Huw M. (COO & CBO) has filed a Form 3 on Stoke Therapeutics, Inc. |
|
|